Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement
Margaret Cristina da Silva Boguszewski(Hospital de Clínicas Universidade Federal do Paraná), Gudmundur Johannsson(Sahlgrenska University Hospital), Claire Higham(Manchester Academic Health Science Centre), Sally Radovick(University of Arizona), Hermann L. Müller(Klinikum Oldenburg), Alberto Fernández(Hospital Universitario de Móstoles), P. Pennisi(Hospital General de Niños Ricardo Gutierrez), Vera Popović(University of Belgrade), Xiaoping Luo(Tongji Hospital), Nathalie Alos(Centre Hospitalier Universitaire Sainte-Justine), Adriane Cardoso-Demartini(Hospital de Clínicas Universidade Federal do Paraná), Judith Gebauer(University Hospital Schleswig-Holstein), Peter Clayton(Manchester Academic Health Science Centre), Lars Sävendahl(Karolinska University Hospital), Maya Lodish(University of California, San Francisco), Manoel H Aguiar Oliveira(Universidade Federal de Sergipe), Kevin C.J. Yuen(Swedish Medical Center), Philippe Touraine(Sorbonne Université), Ken K. Y. Ho(Garvan Institute of Medical Research), Hanneke M. van Santen(University Medical Center Utrecht), John J. Kopchick(University of Maryland, Baltimore), Adda Grimberg(Children's Hospital of Philadelphia), Martin Bidlingmaier(LMU Klinikum), César Luiz Boguszewski(Universidade Federal do Paraná), Laurie E. Cohen(Boston Children's Hospital), Kolbeinn Guðmundsson(National University Hospital of Iceland), Шломо Мелмед(Cedars-Sinai Medical Center), Stefano Cianfarani(University of Rome Tor Vergata), Michel Polak(Hôpital Necker-Enfants Malades), Niki Karavitaki(University Hospitals Birmingham NHS Foundation Trust), Wassim Chemaitilly(St. Jude Children's Research Hospital), Beverley M K Biller(Massachusetts General Hospital), Keiichi Ozono(Osaka Gakuin University), Jaime Guevara‐Aguirre(Unknown), Peter Kamenický(Inserm), R. Coutant(Centre Hospitalier Universitaire de Tours), Lillian R. Meacham(Children's Healthcare of Atlanta), Zoltan Antal(Memorial Sloan Kettering Cancer Center), Jens Otto Lunde Jørgensen(Aarhus University Hospital), Ann McCormack(Garvan Institute of Medical Research), George Brabant(University of Manchester), Andrea M. Isidori(Policlinico Umberto I), Sebastian J C M M Neggers(Erasmus University Rotterdam), Catherine S Choong(The University of Western Australia), Reiko Horikawa(National Center For Child Health and Development), Sogol Mostoufi‐ Moab(Children's Hospital of Philadelphia), Andrew R. Hoffman(Stanford University)
Cited by 111
Related Papers
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
|Hormone Research in Paediatrics|2015|3.1k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763